جست‌وجوی استاد و پژوهشگر

• Cancer Immunology
• Gastrointestinal Pathology
• Liver Pathology
• +۷ مورد دیگر

Haris Mirza is an Assistant Professor of Pathology at Yale School of Medicine, where he serves as a physician-scientist with subspecialty training in Gastrointestinal and Liver Pathology. He is affiliated with the Department of Pathology, Yale Cancer Center, Cancer Immunology, and the Yale Combined Program in the Biological and Biomedical Sciences (BBS). His research is centered on the immune system’s role in colon cancer and other inflammatory diseases. MBBS, DOW Medical College (2006) PhD, National University of Singapore (2012) Postdoctoral Fellowship, Yale School of Medicine (2016) Residency, Yale School of Medicine (2020) Fellowship in GI & Liver Pathology, Yale School of Medicine (2023) Dr. Mirza's research focuses on cancer immunology, particularly the function of CD8+ T cells in melanoma and colon cancer, inflammasome activation in viral infections like COVID-19, and liver immunopathology. His work integrates molecular pathology with translational immunology to understand disease mechanisms and identify therapeutic targets. His recent publications, appearing in Nature , Cell , and PNAS , reveal critical insights into T cell memory, endothelial regulation of liver metabolism, and macrophage-driven inflammation in severe infections. These studies highlight his expertise in humanized mouse models and immune cell profiling. Scientific honors include: Career Development Award (K08) from the National Cancer Institute (2023) James Hudson Brown – Alexander Brown Coxe Fellowship (Yale, 2014) Dr. Mirza actively collaborates with leading scientists such as Akiko Iwasaki, Richard Flavell, and Esen Sefik. He has contributed to major research initiatives in cancer immunology and infectious disease, and his work is supported by competitive grants including the NIH K08. He mentors students and postdoctoral researchers within the BBS and Medical Scientist Training Programs. Dr. Mirza is a member of the Janeway Society, reflecting his role in physician-scientist development at Yale.

Sarah E. Sheppardمشاهده پروفایل

پزشک-پژوهشگر

• Lymphatic Malformations
• Vascular Anomalies
• Genetic Skin Disorders
• +۱۲ مورد دیگر

Sarah E. Sheppard, M.D., Ph.D., M.S.T.R., is a Physician Scientist at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH). She leads the Unit on Vascular Malformations, focusing on translational research into lymphatic and vascular anomalies. Her work integrates clinical investigation with molecular and genetic research to advance diagnosis and therapy for rare disorders. Dr. Sheppard’s research centers on central conducting lymphatic anomaly (CCLA), genetic skin disorders (e.g., epidermal nevus and Wiedemann-Steiner syndromes), and somatic mosaicism in vascular malformations. She utilizes zebrafish and organoid models to study disease mechanisms and test therapies, particularly MEK inhibitors for KRAS-related lymphatic disorders. Her clinical research includes natural history studies to improve diagnostic precision and clinical trial design. She has contributed significantly to understanding the genetic etiologies of CCLA and genotype-phenotype correlations. Her recent publications highlight trends in genomic medicine, targeted therapy, and multidisciplinary care for rare diseases. She frequently publishes in high-impact journals such as Nature Medicine , Science Translational Medicine , and The Journal of Clinical Investigation , with a focus on molecular diagnostics, translational models, and clinical phenotyping. Dr. Sheppard has mentored numerous trainees and collaborators, though specific advisees are not listed. She participates in clinical and research grants related to rare diseases and vascular anomalies. Her work is supported by the NIH Intramural Research Program. She is involved in multidisciplinary teams and leads a research unit focused on vascular malformations. Her lab conducts both wet-lab and clinical investigations, bridging basic science with patient care. She also contributes to national and international collaborations in genetics and rare diseases.

Geoffrey Pottsمشاهده پروفایل

دانشیار

• Dermatology
• Medical Dermatology
• Psoriasis
• +۶ مورد دیگر

Dr. Geoffrey Potts is an Associate Professor and Associate Program Director in the Department of Dermatology at Wayne State University, with a concurrent adjunct appointment at Oakland University William Beaumont School of Medicine. His clinical practice spans medical dermatology, psoriasis, hyperhidrosis, and atopic dermatitis, supported by leadership in multicenter clinical trials. Education: BS in Microbiology (Oakland University, 2007) MD (Wayne State University, 2011) Internal Medicine Training (St. John Hospital, 2012) Dermatology Research Fellowship (St. Louis University, 2014) Dermatology Residency (Wayne State University, 2017) Research Focus: Dr. Potts investigates hyperhidrosis, vitiligo, psoriasis, and atopic dermatitis through industry-sponsored trials (e.g., Incyte, Pfizer, Regeneron). His work emphasizes therapeutic innovation, including JAK inhibitors and biologics, with additional studies on dermatologic terminology comprehension and diversity in academic leadership. Publication Trends: Recent articles (2022-2024) highlight evidence-based reviews of hyperhidrosis therapies, dermatologic surgery anxiety management, social media's role in patient education, and diversity in medicine. Case reports document rare conditions like Rosai-Dorfman disease and Hailey-Hailey disease. Awards: Arnold P. Gold Humanism Honor Society (2024) Core Faculty of the Year (Wayne State Dermatology, 2020, 2023, 2024) Faculty Mentor Award (Dermatology Interest Group Association, 2022) College Teaching Award (Wayne State School of Medicine, 2021) Grants & Advising: As Principal Investigator for 10+ clinical trials, Dr. Potts secures industry funding for dermatologic therapeutics. He mentors residents in research methodology and career development but has no listed PhD/Master's advisees.

Sharon A. Glickمشاهده پروفایل

استاد بالینی

• Pediatric Dermatology
• Skin of Color
• Infantile Hemangiomas
• +۶ مورد دیگر

Sharon A. Glick is a Clinical Professor of Dermatology and Pediatrics at SUNY Downstate Health Sciences University, serving as Chair of the Department of Dermatology and Director of Pediatric Dermatology at multiple institutions including Kings County Hospital Center and Maimonides Medical Center. She is also Residency Program Director at SUNY Health Sciences University. Education: BS from Purdue University, MS from Sarah Lawrence College, MD from Albert Einstein College of Medicine Certifications: Board Certified in Dermatology and Pediatric Dermatology Research Focus: Dr. Glick specializes in pediatric dermatology with emphasis on skin of color , infantile hemangiomas , atopic dermatitis , and genetic skin disorders . Her work bridges clinical practice and academic research, including advocacy for improved representation of skin conditions in diverse populations. Scientific Contributions: With over 110 peer-reviewed publications, she explores vascular anomalies, inflammatory dermatology, and medical education. Her collaborations with Positive Exposure highlight patient advocacy. Key Awards: SUNY Chancellor's Award for Excellence in Teaching SUNY Residents Alumni Society Award for Graduate Medical Education Castle Connolly Top Doctor since 2011 Memberships: ISSVA, PeDRA, American Academy of Dermatology, American Academy of Pediatrics Clinical Practice: Located at Brooklyn, NY (460 Lenox Road) with availability for appointments via phone.

• Genodermatoses
• Epidermolysis Bullosa
• Gene Editing
• +۵ مورد دیگر

Dr. Josefina Pinon Hofbauer is a dedicated researcher and group leader at the Research Program for Molecular Therapy in Genodermatoses within the University Clinic for Dermatology and Allergology at Medical University of Vienna. With over two decades of research activity, she focuses on genodermatoses , particularly epidermolysis bullosa , integrating gene editing , antisense oligonucleotides , and drug repositioning to develop innovative therapies. Research Themes : Her work bridges molecular therapy , scar formation , and collagen type VII biology, addressing critical challenges in rare skin disease clinical trials. Scientific Awards : Notable recognitions include the PMU Wissenschaftspreis Gold (2011) PMU Wissenschaftspreis Silver (2012) Sanofi Award (2011) Wilhelm Türk Preis (2010) Advising : She supervised Marie-Katharina Pichler's master's thesis on hyaluronic acid effects in epidermolysis bullosa keratinocytes. Leadership in Conferences : Actively organizing events like the ÖGDV Science Days (2023-2025) and participating in the EADV Congress 2024 as a guest speaker.

Loretta Davisمشاهده پروفایل

استاد

• Dermatology
• Autoimmune Skin Diseases
• Medical Dermatology
• +۳ مورد دیگر

Loretta Davis is a Professor and Department Chair at the Medical College of Georgia, specializing in Dermatology and Medicine. She serves as the Sanders & Dana Callaway Endowed Chair in Dermatology, directs the Dermatology Residency Program, and acts as Medical Director of the dermatology practice site. Her roles span clinical leadership, education, and advanced dermatological research. Education: MD from Ohio State University (1982), BA in Chemistry from Miami University (1979) Certifications: American Board of Dermatology (1988), American Board of Internal Medicine (1985), National Board of Medical Examiners (1983) Her research focuses on complex dermatological conditions, including autoimmune skin diseases, cutaneous manifestations of systemic illnesses, and pediatric dermatology. Recent scholarship explores vaccine-induced skin reactions and rare genetic syndromes. Recent publications (2022-2023) highlight clinical case studies in inflammatory skin disorders, vaccine-related dermatopathology, and pharmacological trends in geriatric dermatology. Keywords span Autoimmune Dermatology, Pediatric Dermatology, and Medical Dermatology. Patient Care Hero Award (2019) Exemplary Teaching Award (2018, 2016) Exceptional Women in Medicine (2017) She engages in professional service as a member of the American Academy of Dermatology (since 1988) and the Lupus Foundation of America (since 2015). Her teaching includes advanced courses in medical dermatology and cutaneous manifestations of systemic disease.

• Dermatology
• Genetic Skin Disorders
• Autoimmune Blistering Diseases
• +۴ مورد دیگر

Dr. Marieke Bolling is a physician scientist and dermatologist affiliated with the Faculty of Medical Sciences at the University of Groningen. She practices at the UMCG (University Medical Center Groningen) and serves as Medical Coordinator of the Multidisciplinary EB Team and Genodermatoses Consultations . Her work focuses on Epidermolysis Bullosa (EB) , Autoimmune Blistering Diseases , and Genetic Skin Disorders . Marieke Bolling's research leverages Next-Generation Sequencing and Long-Read Sequencing to advance genome diagnostics for EB, while exploring Er:YAG Ablative Laser Therapy for Hailey-Hailey disease. She contributes to European Reference Network initiatives and develops Care Pathways for EB Patients , particularly in Oral Health . Her collaborations span Molecular Biology , Genetics , and Clinical Dermatology disciplines. She received the Best Presentation Award at the 2009 Nederlandse Vereniging voor Experimentele Dermatologie (NVED) meeting for her work on Keratin 1 Founder Mutations . Her publications address Peptidoglycan Microarrays for antibody profiling, EGFR Inhibition in desmosome disorders, and Alitretinoin Therapy for ichthyosis in women. Marieke Bolling is also involved in Stevens-Johnson Syndrome research through antibody analysis and Quality of Life Studies for EB patients. Contact: m.c.bolling@umcg.nl

Alexander Navariniمشاهده پروفایل

مدرس

• Dermatology
• Immunology
• Neutrophil-Mediated Inflammatory Diseases
• +۳ مورد دیگر

Prof. Dr. Alexander Navarini is a Lecturer at the Department of Health Sciences and Technology (D-HEST) at ETH Zurich, with an affiliated Professorship at Universität Zürich (UZH). He serves as Chief Dermatologist & Allergologist at Universitätsspital Basel, specializing in clinical and research activities related to inflammatory skin conditions. His research focuses on mechanisms and treatments for neutrophil-mediated inflammatory diseases (NMID), including pustular psoriasis, pyoderma gangrenosum, and Sweet syndrome. His interdisciplinary team combines computer scientists, biomedical researchers, and clinician-scientists to address immune-mediated skin disorders. Key research groups include DermAIverse, Skin mechanisms and targets @DBM, Digital Dermatology @DBE, and the Skin, Allergy and Immunology Trial Unit @DKF. Clinical activities are based at the Felix Platter Hospital in Basel, while wet-lab research is conducted at the Department of Biomedical Research. He leads the Navarini Lab, offering specialized consultations for genodermatoses using modern genomic techniques. Professional networks include affiliations with the University of Basel and collaborative appointments at UZH.

Hans Henniesمشاهده پروفایل

مدرس ارشد

• Genetic skin diseases
• Congenital ichthyoses
• Epidermal development
• +۸ مورد دیگر

Dr. Hans Hennies is a Senior Lecturer in the Faculty of Health, Education, Policing and Sciences at Staffordshire University. He holds a PhD in Human Genetics from Freie Universität Berlin and a Master's in Biochemistry from the same institution. Previously, he led research groups at the Cologne Center for Genomics, University of Cologne, and Medical University of Innsbruck. His research focuses on genetic skin disorders, particularly congenital ichthyoses, using 3D full-skin models to study epidermal development and barrier function. He develops patient-specific disease models using iPS cells and explores therapeutic applications of recombinant proteins. His work has been funded by major research bodies, and he serves on the board of the European Network for Skin Engineering and Modeling. Dr. Hennies has extensive teaching experience in medical genetics, genomics, physiology, and pathology across BSc and MSc programs in biology and biomedical sciences. His recent publications primarily investigate molecular mechanisms of skin diseases, therapeutic interventions for keratinization disorders, and genotype-phenotype correlations in rare dermatological conditions.

• Gene Therapy
• Stem Cell Biology
• Skin Disorders
• +۵ مورد دیگر

**Michele DE LUCA** is a **Full Professor** at the **University of Modena and Reggio Emilia**, affiliated with the **Department of Life Sciences (former Biomedical Sciences)**. His research focuses on **gene therapy**, **epidermal stem cell biology**, and **regenerative medicine**, particularly targeting genetic skin disorders like **epidermolysis bullosa (EB)** and **lamellar ichthyosis**. He leads clinical trials (e.g., Hologene 5) and pioneered **ex vivo gene-corrected epidermal stem cell transplantation**, enabling long-term skin regeneration in severe cases. His work integrates **CRISPR/Cas9 editing**, **transcriptomics**, and **epigenetic studies** to advance therapeutic strategies for **genodermatoses**. **Education & Research**: DE LUCA’s expertise spans **molecular biology**, **cellular models**, and **clinical translation** of stem cell therapies. His lab develops tools like **AlPaCas** (CRISPR allele-specific editing) and investigates mechanisms like **FOXM1/YAP signaling** in epidermal stem cell regulation. He collaborates internationally on **protein replacement therapies** and **cellular reprogramming**. **Publications**: Over 150 articles (2024–2009) highlight his contributions to **gene therapy efficacy**, **epithelial engineering**, and **clinical outcomes**. Notable works include *Regeneration of the entire human epidermis* (2018), *Allele-specific CRISPR editing* (2024), and *FOXM1-dependent histone regulation* (2024). **Awards & Grants**: Though no explicit awards listed, his work received EU funding for trials and **Holoclar** (first EU-approved stem cell therapy). He advocates for **regulatory compliance** in advanced therapies and critiques unproven stem cell interventions. **Labs & Teams**: Leads interdisciplinary teams at the **University of Modena**, collaborating with clinicians, engineers, and bioinformaticians. Focus areas include **next-generation sequencing for EB diagnosis** and **3D skin equivalents** for preclinical testing.

Donald Glassمشاهده پروفایل

استاد

• Keloid Formation Genetics
• Rare Skin Disorders
• Genodermatoses
• +۳ مورد دیگر

Donald Glass is a Professor of Dermatology at the University of Texas Southwestern Medical Center, where he leads the Glass Lab. His research focuses on genetic and molecular mechanisms underlying keloid formation and rare skin disorders such as pure hair and nail ectodermal dysplasia. Dr. Glass completed his MD and PhD at Baylor College of Medicine, followed by dermatology residency and a postdoctoral fellowship at UT Southwestern. He is board certified by the American Board of Dermatology and actively practices general dermatology with a focus on genetic skin disorders. Education & Training: PhD in Human Genetics, Baylor College of Medicine (2005) MD, Baylor College of Medicine (2006) Residency in Dermatology, UT Southwestern Medical Center Postdoctoral Fellowship, McDermott Center (Helen Hobbs Lab) Research Interests: Genetic predisposition to keloids, particularly in populations of color Identification of genes causing rare skin disorders (e.g., PHNED, CAP syndrome) Keloid registry development for biomarker discovery Molecular pathways in skin fibrosis and wound healing Publications: Dr. Glass has published widely on keloid pathogenesis, genodermatoses, and dermatological therapeutics. Recent work includes studies on pentoxifylline for keloid prevention, genetic mutations in ectodermal dysplasia, and patient adherence to dermatologic medications. Awards & Affiliations: Active member of the American Academy of Dermatology. Honors include recognition for contributions to keloid research (specific awards unspecified). Labs & Teams: The Glass Lab employs multidisciplinary approaches combining genetics, molecular biology, and clinical studies. Collaborations focus on translational research to develop therapies for keloids and inherited skin diseases.

• Dermatology
• Epidemiology
• Comorbidities
• +۵ مورد دیگر

Goli Compoginis is a Clinical Assistant Professor of Dermatology at the University of Southern California, specializing in clinical education. Their research focuses on dermatologic epidemiology, treatment patterns, and adverse drug reactions in skin disorders. Research Interests Key areas include alopecia areata , trichotillomania , and WRN mutations in genetic syndromes, with applications in pharmacovigilance and immunomodulatory therapies. Publications Recent work spans epidemiologic studies of autoimmune skin diseases and toxicity analysis of targeted cancer therapies, reflecting interdisciplinary approaches to dermatology and pharmacology. Collaborations No explicit information on labs, teams, or grants is provided in the available text.

• Dermatology
• Molecular Genetics
• Cutaneous Inflammation
• +۳ مورد دیگر

Dr. Raymond Cho is a Professor of Dermatology at the University of California, San Francisco (UCSF), School of Medicine. He specializes in molecular genetics of skin diseases and co-directs the RashX initiative, focusing on precision transcriptomic biomarkers for skin inflammation. His research spans cutaneous cancer genetics, including NOTCH receptor mutations in squamous cell carcinomas and APOBEC-driven carcinogenesis in epidermolysis bullosa. He holds grants from NIH, Janssen, and industry partners, and has received awards such as the American Academy of Dermatology Young Investigator Award and LEO Foundation Grant. Education: MD and PhD in Genetics from Stanford University School of Medicine (2005/2003). Co-founded Ingenuity Systems, now part of Qiagen. Research interests include single-cell transcriptomics, cancer genomics, and inflammatory skin disorders. Key achievements include discovering SUFU loss-of-function in basal cell carcinoma and distinct cell origins in sebaceous carcinoma. Over 150 peer-reviewed publications, with contributions to understanding APOBEC mutagenesis and IL-23 inhibition therapies. Awards: Listed above. Active in international lectures and collaborations, including work with Dr. Andrew South on APOBEC-driven cancers. His lab integrates spatial omics and computational methods for skin disease diagnostics.

• Skin Cancer
• Molecular Genetics
• Dermatologic Surgery
• +۴ مورد دیگر

Sean Christensen, MD, PhD, is an Associate Professor of Dermatology at Yale University School of Medicine, serving as Director of Resident Education in Dermatologic Surgery and Director of Dermatologic Surgery at Yale Dermatology-Branford. His clinical practice focuses on skin cancer management, including Mohs micrographic surgery, reconstructive surgery, and field cancerization strategies. Research interests include molecular mechanisms of skin cancer development, UV-induced mutations, and optimizing preventive therapies. He leads a phase III clinical trial for a novel topical basal cell carcinoma treatment. Education: MD from Yale University School of Medicine (2007), PhD from Yale Graduate School (2006), BS from University of California (1998). Completed residency and a procedural dermatology fellowship at Yale SOM. Research highlights include defining follicular invasion markers in SCC, evaluating acitretin for skin cancer prevention, and comparing Mohs vs wide excision for melanoma outcomes. Awards include multiple Connecticut Top Doctors recognitions (2023, 2024). Leads clinical trials investigating UV exposure biomarkers and skin cancer risk.

• Oral Cancer Tumor Microenvironment
• Biomarkers
• Clinical Oral and Maxillofacial Pathology
• +۲ مورد دیگر

Associate Professor Muhammed Yakin is affiliated with the Adelaide Dental School at the University of Adelaide . His research focuses on oral cancer tumor microenvironment and biomarkers , clinical oral and maxillofacial pathology , and dental education . He serves as a co-supervisor for higher degree research candidates. Academic Rank: Associate Professor University: University of Adelaide School: Adelaide Dental School, Faculty of Health and Medical Sciences His research explores molecular mechanisms in oral carcinogenesis, including endoplasmic reticulum stress and cytokine regulation, alongside epidemiological studies of oral diseases. He has investigated biomarkers for cyst recurrence and HPV-related oropharyngeal cancers, contributing to diagnostic and therapeutic advancements. Recent publications highlight his work in oral tumor classification, dental caries pathology, and adaptive e-learning in dental education. These studies span oral oncology , pathobiology , and educational technology domains. Scientific Awards: IADR/Unilever-Hatton Divisional Award (2013), Best Oral Presentation Prize (2016) Grants: Doctoral Scholarship (University of Otago, 2013), Fuller Research Scholarship (2014), NZ Dental Association Research Foundation grants (2015, 2016) He is currently pursuing a PhD in the epidemiology of oral and maxillofacial pathology , further solidifying his expertise in this field.